4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-20-001806
CEO acquired 262,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Woods Lori A CEO | 2020-02-03 | Option exercise | +75,000 | $0.61 | $45,375 | 355,000 | I: show line 1 in the form |
| Woods Lori A CEO | 2020-02-03 | Option exercise | +125,000 | $0.46 | $57,500 | 480,000 | I: show line 2 in the form |
| Woods Lori A CEO | 2020-02-03 | Option exercise | +62,500 | $0.43 | $26,875 | 542,500 | I: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Woods Lori A CEO | 2020-02-03 | Option exercise · Stock Options (right to buy) | −75,000 | 25,000 | D: show line 4 in the form | ||
| Woods Lori A CEO | 2020-02-03 | Option exercise · Stock Options (right to buy) | −125,000 | 125,000 | D: show line 5 in the form | ||
| Woods Lori A CEO | 2020-02-03 | Option exercise · Stock Options (right to buy) | −62,500 | 187,500 | D: show line 6 in the form |
Loading xslF345X03/rdgdoc.xml…